Metabolic Phenotypes in Melanoma
ConditionMelanoma
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorPeter MacCallum Cancer Centre, Australia
About this trial
This is a single centre, correlative, longitudinal, biomarker study that aims to describe the metabolic features of human melanoma using mass spectrometry.
Eligibility criteria
Qualifiers
Patient has provided written informed consent
Male or female aged 18 years or older at written informed consent
Presence of a known melanoma lesion requiring surgical excision or biopsy
Patient is willing and able to comply with the protocol for the duration of the study including undergoing biopsies and receiving a stable isotope infusion (where applicable)
Disqualifiers
Diabetes mellitus
Pregnancy or breast feeding
Patients unable to comply with study procedures and follow up in the opinion of the investigator
Trial design
Treatments tested in this trial
- [U-13C]Glucose Infusion
Treatment groups
240 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov